Linezolid Aurobindo

Linezolid, the active ingredient in Linezolid Aurobindo, is an oxazolidinone presented as an intravenous formulation for parenteral use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients.

GNH USA supplies Linezolid Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibacterial used for serious Gram‑positive infections.

- Complicated skin and soft‑tissue infections: provides effective coverage against MRSA and other resistant Gram‑positive pathogens. - Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: offers bactericidal activity for resistant Gram‑positive organisms. - Infections caused by vancomycin‑resistant Enterococcus (VRE): serves as an alternative intravenous option for these difficult‑to‑treat infections.

Linezolid may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Metallic taste: altered taste sensation during therapy.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Peripheral neuropathy: nerve damage that can be irreversible if untreated. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Optic neuropathy: visual disturbances that may be permanent.

Before initiating Linezolid therapy, consider the following safety measures.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use with caution and observe liver enzymes. - Concomitant serotonergic agents: avoid due to risk of serotonin syndrome. - Prolonged therapy (>14 days): perform regular complete blood count monitoring. - Pregnancy and lactation: safety not established; weigh benefits against risks. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze.

Linezolid can interact with several drug classes; awareness of the interaction level is essential.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): may precipitate serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): increase risk of serotonin toxicity. - Rifampicin: induces metabolism, reducing linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Phenytoin: may lower linezolid levels, affecting efficacy. - Erythromycin: can increase linezolid exposure, necessitating dose review.